Cargando…

Human Cytomegalovirus Latency and Reactivation in Allogeneic Hematopoietic Stem Cell Transplant Recipients

Human cytomegalovirus (HCMV) reactivation is a major infectious cause of morbidity and mortality after allogeneic hematopoietic stem cell transplantation (HSCT). HCMV is a ubiquitous beta-herpesvirus which asymptomatically infects immunocompetent individuals but establishes lifelong latency, with th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stern, Lauren, Withers, Barbara, Avdic, Selmir, Gottlieb, David, Abendroth, Allison, Blyth, Emily, Slobedman, Barry
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6546901/ https://www.ncbi.nlm.nih.gov/pubmed/31191499 http://dx.doi.org/10.3389/fmicb.2019.01186

Ejemplares similares

Profiling the Blood Compartment of Hematopoietic Stem Cell Transplant Patients During Human Cytomegalovirus Reactivation
por: Bernshtein, Biana, et al.
Publicado: (2021)

Circulating cytokine and chemokine patterns associated with cytomegalovirus reactivation after stem cell transplantation
por: Stern, Lauren, et al.
Publicado: (2023)

Immunoprofiling reveals cell subsets associated with the trajectory of cytomegalovirus reactivation post stem cell transplantation
por: Stern, Lauren, et al.
Publicado: (2022)

Mass cytometry reveals immune signatures associated with cytomegalovirus (CMV) control in recipients of allogeneic haemopoietic stem cell transplant and CMV‐specific T cells
por: McGuire, Helen M, et al.
Publicado: (2020)

Mass Cytometry for the Assessment of Immune Reconstitution After Hematopoietic Stem Cell Transplantation
por: Stern, Lauren, et al.
Publicado: (2018)

Single cell analysis reveals human cytomegalovirus drives latently infected cells towards an anergic-like monocyte state
por: Shnayder, Miri, et al.
Publicado: (2020)

Human Cytomegalovirus Encoded Homologs of Cytokines, Chemokines and their Receptors: Roles in Immunomodulation
por: McSharry, Brian P., et al.
Publicado: (2012)

Modulation of dendritic cell functions by viral IL-10 encoded by human cytomegalovirus
por: Avdic, Selmir, et al.
Publicado: (2014)

Latency-Associated Viral Interleukin-10 (IL-10) Encoded by Human Cytomegalovirus Modulates Cellular IL-10 and CCL8 Secretion during Latent Infection through Changes in the Cellular MicroRNA hsa-miR-92a
por: Poole, Emma, et al.
Publicado: (2014)

Whole-Genome Approach to Assessing Human Cytomegalovirus Dynamics in Transplant Patients Undergoing Antiviral Therapy
por: Suárez, Nicolás M., et al.
Publicado: (2020)

Interferon-Independent Innate Responses to Cytomegalovirus
por: Ashley, Caroline L., et al.
Publicado: (2019)

923. Respiratory Syncytial and Parainfluenza Virus Infection Increase the Risk of Cytomegalovirus Reactivation in Allogeneic Hematopoietic Cell Transplant Recipients
por: Xie, Hu, et al.
Publicado: (2021)

926. Risk factors for post-letermovir cytomegalovirus (CMV) reactivation in allogeneic hematopoietic stem cell transplant (HSCT) recipients
por: Mendoza, Maria Alejandra, et al.
Publicado: (2023)

Interferon-Independent Upregulation of Interferon-Stimulated Genes during Human Cytomegalovirus Infection is Dependent on IRF3 Expression
por: Ashley, Caroline L., et al.
Publicado: (2019)

Third-party CMV- and EBV-specific T-cells for first viral reactivation after allogeneic stem cell transplant
por: Jiang, Wei, et al.
Publicado: (2022)

Prophylactic antigen‐specific T‐cells targeting seven viral and fungal pathogens after allogeneic haemopoietic stem cell transplant
por: Gottlieb, David Jonathan, et al.
Publicado: (2021)

The association of conditioning regimen with cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation
por: Mardani, Masoud, et al.
Publicado: (2020)

Epigenetic Control of Cytomegalovirus Latency and Reactivation
por: Liu, Xue-feng, et al.
Publicado: (2013)

Varicella zoster virus encodes a viral decoy RHIM to inhibit cell death
por: Steain, Megan, et al.
Publicado: (2020)

A Mortality Analysis of Letermovir Prophylaxis for Cytomegalovirus (CMV) in CMV-seropositive Recipients of Allogeneic Hematopoietic Cell Transplantation
por: Ljungman, Per, et al.
Publicado: (2020)

Proven Cytomegalovirus Colitis Associated with Dasatinib Administration in Two Pediatric Allogeneic Hematopoietic Stem Cell Transplantation Recipients
por: Kim, Jeong Min, et al.
Publicado: (2023)

928. Concordance with Institutional Guidelines for Letermovir Cytomegalovirus Infection Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplant Recipients
por: Peterson-Weber, Alex, et al.
Publicado: (2023)

Cost-effectiveness analysis of the use of letermovir for the prophylaxis of cytomegalovirus in adult cytomegalovirus seropositive recipients undergoing allogenic hematopoietic stem cell transplantation in Italy
por: Restelli, Umberto, et al.
Publicado: (2019)

Cytomegalovirus (CMV) genotype in allogeneic hematopoietic stem cell transplantation
por: Dieamant, Débora C, et al.
Publicado: (2013)

Cytomegalovirus monitoring in allogeneic haemopoietic stem cell transplant recipients
por: Ramalingam, S., et al.
Publicado: (2006)

Murine Cytomegalovirus Immediate-Early 1 Gene Expression Correlates with Increased GVHD after Allogeneic Hematopoietic Cell Transplantation in Recipients Reactivating from Latent Infection
por: Palaniyandi, Senthilnathan, et al.
Publicado: (2013)

Clinical Usefulness of Monitoring Cytomegalovirus-Specific Immunity by Quantiferon-CMV in Pediatric Allogeneic Hematopoietic Stem Cell Transplantation Recipients
por: Lee, Sae-Mi, et al.
Publicado: (2017)

Pulmonary cytomegalovirus (CMV) DNA shedding in allogeneic hematopoietic stem cell transplant recipients: Implications for the diagnosis of CMV pneumonia
por: Piñana, José Luis, et al.
Publicado: (2019)

Molecular Determinants and the Regulation of Human Cytomegalovirus Latency and Reactivation
por: Collins-McMillen, Donna, et al.
Publicado: (2018)

Regulation of Latency and Reactivation by Human Cytomegalovirus miRNAs
por: Diggins, Nicole L., et al.
Publicado: (2021)

Advances in Model Systems for Human Cytomegalovirus Latency and Reactivation
por: Crawford, Lindsey B., et al.
Publicado: (2022)

Another tool against cytomegalovirus after allogeneic hematopoietic cell transplantation
por: Chen, George L., et al.
Publicado: (2023)

Strongyloides stercoralis, Human T-cell Lymphotropic Virus Type-1 and Cytomegalovirus Coinfection in an Allogeneic Hematopoietic Stem-Cell Transplant Recipient
por: Rahman, Farah, et al.
Publicado: (2020)

Association between Antiviral Prophylaxis and Cytomegalovirus and Epstein–Barr Virus DNAemia in Pediatric Recipients of Allogeneic Hematopoietic Stem Cell Transplant
por: Diop, Ndeye Soukeyna, et al.
Publicado: (2021)

Donor–Recipient Story in Allogeneic Hematopoietic Stem Cell Transplantation
por: Kum, Elena, et al.
Publicado: (2021)

Cutaneous Legionella infections in allogeneic hematopoietic cell transplantation recipients
por: Vaidya, Toral, et al.
Publicado: (2020)

Allogeneic Hematopoietic Cell Transplantation and Cellular Therapy
por: Kim, Hee-Je, et al.
Publicado: (2021)

Cytomegalovirus Latency and Reactivation: An Intricate Interplay With the Host Immune Response
por: Forte, Eleonora, et al.
Publicado: (2020)

Modulation of host cell signaling during cytomegalovirus latency and reactivation
por: Smith, Nicholas A., et al.
Publicado: (2021)

A Mortality Analysis of the Cytomegalovirus (CMV) Infection Letermovir Prophylaxis Trial in CMV-Seropositive Recipients of Allogeneic Hematopoietic Cell Transplantation (HCT)
por: Maertens, Johan, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_6lgntnrv85o58qdhevh437gosf